nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvastatin—SLCO1B3—Methotrexate—lymphatic system cancer	0.117	0.16	CbGbCtD
Fluvastatin—CYP1A2—Carmustine—lymphatic system cancer	0.114	0.156	CbGbCtD
Fluvastatin—CYP3A5—Teniposide—lymphatic system cancer	0.103	0.141	CbGbCtD
Fluvastatin—CYP2C19—Teniposide—lymphatic system cancer	0.0831	0.113	CbGbCtD
Fluvastatin—CYP2C9—Teniposide—lymphatic system cancer	0.0691	0.0943	CbGbCtD
Fluvastatin—SLCO1B1—Methotrexate—lymphatic system cancer	0.0682	0.0931	CbGbCtD
Fluvastatin—CYP3A5—Vincristine—lymphatic system cancer	0.0496	0.0677	CbGbCtD
Fluvastatin—CYP3A4—Cytarabine—lymphatic system cancer	0.0408	0.0557	CbGbCtD
Fluvastatin—CYP3A4—Teniposide—lymphatic system cancer	0.0402	0.0548	CbGbCtD
Fluvastatin—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0281	0.0383	CbGbCtD
Fluvastatin—CYP3A4—Vincristine—lymphatic system cancer	0.0193	0.0264	CbGbCtD
Fluvastatin—Sinusitis—Mitoxantrone—lymphatic system cancer	0.000783	0.00293	CcSEcCtD
Fluvastatin—Decreased appetite—Fludarabine—lymphatic system cancer	0.000778	0.00291	CcSEcCtD
Fluvastatin—Visual impairment—Carmustine—lymphatic system cancer	0.000777	0.00291	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000773	0.00289	CcSEcCtD
Fluvastatin—Fatigue—Fludarabine—lymphatic system cancer	0.000772	0.00289	CcSEcCtD
Fluvastatin—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000766	0.00287	CcSEcCtD
Fluvastatin—Pain—Fludarabine—lymphatic system cancer	0.000765	0.00286	CcSEcCtD
Fluvastatin—Constipation—Fludarabine—lymphatic system cancer	0.000765	0.00286	CcSEcCtD
Fluvastatin—Vasculitis—Methotrexate—lymphatic system cancer	0.000762	0.00285	CcSEcCtD
Fluvastatin—Connective tissue disorder—Vincristine—lymphatic system cancer	0.000756	0.00283	CcSEcCtD
Fluvastatin—Rhinitis—Mitoxantrone—lymphatic system cancer	0.000751	0.00281	CcSEcCtD
Fluvastatin—Hypersensitivity—Teniposide—lymphatic system cancer	0.00075	0.00281	CcSEcCtD
Fluvastatin—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00075	0.00281	CcSEcCtD
Fluvastatin—Flushing—Carmustine—lymphatic system cancer	0.000748	0.0028	CcSEcCtD
Fluvastatin—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000746	0.00279	CcSEcCtD
Fluvastatin—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.000744	0.00278	CcSEcCtD
Fluvastatin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000738	0.00276	CcSEcCtD
Fluvastatin—Asthenia—Teniposide—lymphatic system cancer	0.000731	0.00273	CcSEcCtD
Fluvastatin—Malaise—Bleomycin—lymphatic system cancer	0.000725	0.00271	CcSEcCtD
Fluvastatin—Pruritus—Teniposide—lymphatic system cancer	0.00072	0.0027	CcSEcCtD
Fluvastatin—Arrhythmia—Carmustine—lymphatic system cancer	0.00072	0.0027	CcSEcCtD
Fluvastatin—Leukopenia—Bleomycin—lymphatic system cancer	0.00072	0.00269	CcSEcCtD
Fluvastatin—Cardiac disorder—Vincristine—lymphatic system cancer	0.000714	0.00267	CcSEcCtD
Fluvastatin—Alopecia—Carmustine—lymphatic system cancer	0.000712	0.00267	CcSEcCtD
Fluvastatin—Body temperature increased—Fludarabine—lymphatic system cancer	0.000708	0.00265	CcSEcCtD
Fluvastatin—Mental disorder—Carmustine—lymphatic system cancer	0.000706	0.00264	CcSEcCtD
Fluvastatin—Erythema—Carmustine—lymphatic system cancer	0.000702	0.00263	CcSEcCtD
Fluvastatin—Cough—Bleomycin—lymphatic system cancer	0.000702	0.00263	CcSEcCtD
Fluvastatin—Angiopathy—Vincristine—lymphatic system cancer	0.000698	0.00261	CcSEcCtD
Fluvastatin—Diarrhoea—Teniposide—lymphatic system cancer	0.000697	0.00261	CcSEcCtD
Fluvastatin—Chest pain—Bleomycin—lymphatic system cancer	0.000685	0.00256	CcSEcCtD
Fluvastatin—Myalgia—Bleomycin—lymphatic system cancer	0.000685	0.00256	CcSEcCtD
Fluvastatin—Alopecia—Vincristine—lymphatic system cancer	0.00068	0.00255	CcSEcCtD
Fluvastatin—Back pain—Carmustine—lymphatic system cancer	0.000679	0.00254	CcSEcCtD
Fluvastatin—Discomfort—Bleomycin—lymphatic system cancer	0.000676	0.00253	CcSEcCtD
Fluvastatin—Mental disorder—Vincristine—lymphatic system cancer	0.000674	0.00252	CcSEcCtD
Fluvastatin—Chills—Mitoxantrone—lymphatic system cancer	0.000673	0.00252	CcSEcCtD
Fluvastatin—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00067	0.00251	CcSEcCtD
Fluvastatin—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000665	0.00249	CcSEcCtD
Fluvastatin—Alopecia—Mitoxantrone—lymphatic system cancer	0.000662	0.00248	CcSEcCtD
Fluvastatin—Confusional state—Bleomycin—lymphatic system cancer	0.000662	0.00248	CcSEcCtD
Fluvastatin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000659	0.00247	CcSEcCtD
Fluvastatin—Tremor—Carmustine—lymphatic system cancer	0.000658	0.00246	CcSEcCtD
Fluvastatin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000656	0.00246	CcSEcCtD
Fluvastatin—Erythema—Mitoxantrone—lymphatic system cancer	0.000652	0.00244	CcSEcCtD
Fluvastatin—Infection—Bleomycin—lymphatic system cancer	0.000652	0.00244	CcSEcCtD
Fluvastatin—Back pain—Vincristine—lymphatic system cancer	0.000648	0.00243	CcSEcCtD
Fluvastatin—Vomiting—Teniposide—lymphatic system cancer	0.000647	0.00242	CcSEcCtD
Fluvastatin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000643	0.00241	CcSEcCtD
Fluvastatin—Asthenia—Fludarabine—lymphatic system cancer	0.000642	0.0024	CcSEcCtD
Fluvastatin—Rash—Teniposide—lymphatic system cancer	0.000642	0.0024	CcSEcCtD
Fluvastatin—Dermatitis—Teniposide—lymphatic system cancer	0.000641	0.0024	CcSEcCtD
Fluvastatin—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000639	0.00239	CcSEcCtD
Fluvastatin—Headache—Teniposide—lymphatic system cancer	0.000638	0.00239	CcSEcCtD
Fluvastatin—Pruritus—Fludarabine—lymphatic system cancer	0.000633	0.00237	CcSEcCtD
Fluvastatin—Back pain—Mitoxantrone—lymphatic system cancer	0.000631	0.00236	CcSEcCtD
Fluvastatin—Leukopenia—Carmustine—lymphatic system cancer	0.000628	0.00235	CcSEcCtD
Fluvastatin—Anorexia—Bleomycin—lymphatic system cancer	0.000626	0.00234	CcSEcCtD
Fluvastatin—Photosensitivity—Methotrexate—lymphatic system cancer	0.000615	0.0023	CcSEcCtD
Fluvastatin—Diarrhoea—Fludarabine—lymphatic system cancer	0.000612	0.00229	CcSEcCtD
Fluvastatin—Hypertension—Carmustine—lymphatic system cancer	0.000606	0.00227	CcSEcCtD
Fluvastatin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000605	0.00227	CcSEcCtD
Fluvastatin—Nausea—Teniposide—lymphatic system cancer	0.000605	0.00226	CcSEcCtD
Fluvastatin—Vertigo—Vincristine—lymphatic system cancer	0.000602	0.00225	CcSEcCtD
Fluvastatin—Hepatic failure—Methotrexate—lymphatic system cancer	0.000601	0.00225	CcSEcCtD
Fluvastatin—Leukopenia—Vincristine—lymphatic system cancer	0.0006	0.00224	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000598	0.00224	CcSEcCtD
Fluvastatin—Myalgia—Carmustine—lymphatic system cancer	0.000598	0.00224	CcSEcCtD
Fluvastatin—Chest pain—Carmustine—lymphatic system cancer	0.000598	0.00224	CcSEcCtD
Fluvastatin—Anxiety—Carmustine—lymphatic system cancer	0.000595	0.00223	CcSEcCtD
Fluvastatin—Paraesthesia—Bleomycin—lymphatic system cancer	0.000589	0.00221	CcSEcCtD
Fluvastatin—Malaise—Mitoxantrone—lymphatic system cancer	0.000588	0.0022	CcSEcCtD
Fluvastatin—Dyspnoea—Bleomycin—lymphatic system cancer	0.000585	0.00219	CcSEcCtD
Fluvastatin—Renal failure acute—Methotrexate—lymphatic system cancer	0.000585	0.00219	CcSEcCtD
Fluvastatin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000584	0.00219	CcSEcCtD
Fluvastatin—Hypertension—Vincristine—lymphatic system cancer	0.000578	0.00217	CcSEcCtD
Fluvastatin—Confusional state—Carmustine—lymphatic system cancer	0.000578	0.00216	CcSEcCtD
Fluvastatin—Decreased appetite—Bleomycin—lymphatic system cancer	0.00057	0.00214	CcSEcCtD
Fluvastatin—Myalgia—Vincristine—lymphatic system cancer	0.00057	0.00214	CcSEcCtD
Fluvastatin—Cough—Mitoxantrone—lymphatic system cancer	0.000569	0.00213	CcSEcCtD
Fluvastatin—Infection—Carmustine—lymphatic system cancer	0.000569	0.00213	CcSEcCtD
Fluvastatin—Vomiting—Fludarabine—lymphatic system cancer	0.000569	0.00213	CcSEcCtD
Fluvastatin—Rash—Fludarabine—lymphatic system cancer	0.000564	0.00211	CcSEcCtD
Fluvastatin—Dermatitis—Fludarabine—lymphatic system cancer	0.000564	0.00211	CcSEcCtD
Fluvastatin—Hypertension—Mitoxantrone—lymphatic system cancer	0.000563	0.00211	CcSEcCtD
Fluvastatin—Pain—Bleomycin—lymphatic system cancer	0.000561	0.0021	CcSEcCtD
Fluvastatin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000561	0.0021	CcSEcCtD
Fluvastatin—Headache—Fludarabine—lymphatic system cancer	0.000561	0.0021	CcSEcCtD
Fluvastatin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000556	0.00208	CcSEcCtD
Fluvastatin—Chest pain—Mitoxantrone—lymphatic system cancer	0.000556	0.00208	CcSEcCtD
Fluvastatin—Myalgia—Mitoxantrone—lymphatic system cancer	0.000556	0.00208	CcSEcCtD
Fluvastatin—Anxiety—Mitoxantrone—lymphatic system cancer	0.000554	0.00207	CcSEcCtD
Fluvastatin—Discomfort—Mitoxantrone—lymphatic system cancer	0.000549	0.00205	CcSEcCtD
Fluvastatin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000547	0.00205	CcSEcCtD
Fluvastatin—Anorexia—Carmustine—lymphatic system cancer	0.000546	0.00204	CcSEcCtD
Fluvastatin—Infection—Vincristine—lymphatic system cancer	0.000543	0.00203	CcSEcCtD
Fluvastatin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000541	0.00202	CcSEcCtD
Fluvastatin—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00054	0.00202	CcSEcCtD
Fluvastatin—Confusional state—Mitoxantrone—lymphatic system cancer	0.000537	0.00201	CcSEcCtD
Fluvastatin—Nervous system disorder—Vincristine—lymphatic system cancer	0.000536	0.00201	CcSEcCtD
Fluvastatin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000535	0.002	CcSEcCtD
Fluvastatin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000533	0.00199	CcSEcCtD
Fluvastatin—Nausea—Fludarabine—lymphatic system cancer	0.000532	0.00199	CcSEcCtD
Fluvastatin—Infection—Mitoxantrone—lymphatic system cancer	0.000529	0.00198	CcSEcCtD
Fluvastatin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000529	0.00198	CcSEcCtD
Fluvastatin—Shock—Mitoxantrone—lymphatic system cancer	0.000524	0.00196	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000522	0.00195	CcSEcCtD
Fluvastatin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000521	0.00195	CcSEcCtD
Fluvastatin—Urticaria—Bleomycin—lymphatic system cancer	0.000521	0.00195	CcSEcCtD
Fluvastatin—Anorexia—Vincristine—lymphatic system cancer	0.000521	0.00195	CcSEcCtD
Fluvastatin—Body temperature increased—Bleomycin—lymphatic system cancer	0.000519	0.00194	CcSEcCtD
Fluvastatin—Insomnia—Carmustine—lymphatic system cancer	0.000518	0.00194	CcSEcCtD
Fluvastatin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000517	0.00194	CcSEcCtD
Fluvastatin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000515	0.00193	CcSEcCtD
Fluvastatin—Paraesthesia—Carmustine—lymphatic system cancer	0.000514	0.00193	CcSEcCtD
Fluvastatin—Dyspnoea—Carmustine—lymphatic system cancer	0.000511	0.00191	CcSEcCtD
Fluvastatin—Anorexia—Mitoxantrone—lymphatic system cancer	0.000508	0.0019	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000498	0.00186	CcSEcCtD
Fluvastatin—Decreased appetite—Carmustine—lymphatic system cancer	0.000498	0.00186	CcSEcCtD
Fluvastatin—Insomnia—Vincristine—lymphatic system cancer	0.000495	0.00185	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000495	0.00185	CcSEcCtD
Fluvastatin—Paraesthesia—Vincristine—lymphatic system cancer	0.000491	0.00184	CcSEcCtD
Fluvastatin—Pain—Carmustine—lymphatic system cancer	0.00049	0.00183	CcSEcCtD
Fluvastatin—Constipation—Carmustine—lymphatic system cancer	0.00049	0.00183	CcSEcCtD
Fluvastatin—Breast disorder—Methotrexate—lymphatic system cancer	0.000488	0.00183	CcSEcCtD
Fluvastatin—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000486	0.00182	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000485	0.00182	CcSEcCtD
Fluvastatin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000483	0.00181	CcSEcCtD
Fluvastatin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000478	0.00179	CcSEcCtD
Fluvastatin—Decreased appetite—Vincristine—lymphatic system cancer	0.000475	0.00178	CcSEcCtD
Fluvastatin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000475	0.00178	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000472	0.00177	CcSEcCtD
Fluvastatin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000472	0.00177	CcSEcCtD
Fluvastatin—Fatigue—Vincristine—lymphatic system cancer	0.000471	0.00176	CcSEcCtD
Fluvastatin—Asthenia—Bleomycin—lymphatic system cancer	0.000471	0.00176	CcSEcCtD
Fluvastatin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000469	0.00175	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000468	0.00175	CcSEcCtD
Fluvastatin—Pain—Vincristine—lymphatic system cancer	0.000468	0.00175	CcSEcCtD
Fluvastatin—Constipation—Vincristine—lymphatic system cancer	0.000468	0.00175	CcSEcCtD
Fluvastatin—Pruritus—Bleomycin—lymphatic system cancer	0.000464	0.00174	CcSEcCtD
Fluvastatin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000463	0.00173	CcSEcCtD
Fluvastatin—Eosinophilia—Methotrexate—lymphatic system cancer	0.000462	0.00173	CcSEcCtD
Fluvastatin—Fatigue—Mitoxantrone—lymphatic system cancer	0.000459	0.00172	CcSEcCtD
Fluvastatin—Pancreatitis—Methotrexate—lymphatic system cancer	0.000457	0.00171	CcSEcCtD
Fluvastatin—Pain—Mitoxantrone—lymphatic system cancer	0.000455	0.0017	CcSEcCtD
Fluvastatin—Constipation—Mitoxantrone—lymphatic system cancer	0.000455	0.0017	CcSEcCtD
Fluvastatin—Body temperature increased—Carmustine—lymphatic system cancer	0.000453	0.00169	CcSEcCtD
Fluvastatin—Abdominal pain—Carmustine—lymphatic system cancer	0.000453	0.00169	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000447	0.00167	CcSEcCtD
Fluvastatin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000439	0.00164	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000435	0.00163	CcSEcCtD
Fluvastatin—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000434	0.00162	CcSEcCtD
Fluvastatin—Abdominal pain—Vincristine—lymphatic system cancer	0.000432	0.00162	CcSEcCtD
Fluvastatin—Body temperature increased—Vincristine—lymphatic system cancer	0.000432	0.00162	CcSEcCtD
Fluvastatin—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00043	0.00161	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000426	0.00159	CcSEcCtD
Fluvastatin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000423	0.00158	CcSEcCtD
Fluvastatin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000422	0.00158	CcSEcCtD
Fluvastatin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000421	0.00158	CcSEcCtD
Fluvastatin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000421	0.00158	CcSEcCtD
Fluvastatin—Vomiting—Bleomycin—lymphatic system cancer	0.000417	0.00156	CcSEcCtD
Fluvastatin—Infestation—Methotrexate—lymphatic system cancer	0.000416	0.00156	CcSEcCtD
Fluvastatin—Infestation NOS—Methotrexate—lymphatic system cancer	0.000416	0.00156	CcSEcCtD
Fluvastatin—Rash—Bleomycin—lymphatic system cancer	0.000414	0.00155	CcSEcCtD
Fluvastatin—Dermatitis—Bleomycin—lymphatic system cancer	0.000413	0.00155	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000412	0.00154	CcSEcCtD
Fluvastatin—Asthenia—Carmustine—lymphatic system cancer	0.000411	0.00154	CcSEcCtD
Fluvastatin—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000404	0.00151	CcSEcCtD
Fluvastatin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000403	0.00151	CcSEcCtD
Fluvastatin—Sweating—Methotrexate—lymphatic system cancer	0.000399	0.00149	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000393	0.00147	CcSEcCtD
Fluvastatin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000392	0.00147	CcSEcCtD
Fluvastatin—Asthenia—Vincristine—lymphatic system cancer	0.000392	0.00147	CcSEcCtD
Fluvastatin—Diarrhoea—Carmustine—lymphatic system cancer	0.000392	0.00147	CcSEcCtD
Fluvastatin—Nausea—Bleomycin—lymphatic system cancer	0.00039	0.00146	CcSEcCtD
Fluvastatin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000382	0.00143	CcSEcCtD
Fluvastatin—Dizziness—Carmustine—lymphatic system cancer	0.000379	0.00142	CcSEcCtD
Fluvastatin—Diarrhoea—Vincristine—lymphatic system cancer	0.000374	0.0014	CcSEcCtD
Fluvastatin—Hepatitis—Methotrexate—lymphatic system cancer	0.000373	0.0014	CcSEcCtD
Fluvastatin—Pharyngitis—Methotrexate—lymphatic system cancer	0.000371	0.00139	CcSEcCtD
Fluvastatin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000364	0.00136	CcSEcCtD
Fluvastatin—Vomiting—Carmustine—lymphatic system cancer	0.000364	0.00136	CcSEcCtD
Fluvastatin—Dizziness—Vincristine—lymphatic system cancer	0.000362	0.00135	CcSEcCtD
Fluvastatin—Rash—Carmustine—lymphatic system cancer	0.000361	0.00135	CcSEcCtD
Fluvastatin—Dermatitis—Carmustine—lymphatic system cancer	0.000361	0.00135	CcSEcCtD
Fluvastatin—Visual impairment—Methotrexate—lymphatic system cancer	0.00036	0.00135	CcSEcCtD
Fluvastatin—Headache—Carmustine—lymphatic system cancer	0.000359	0.00134	CcSEcCtD
Fluvastatin—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000353	0.00132	CcSEcCtD
Fluvastatin—Vomiting—Vincristine—lymphatic system cancer	0.000348	0.0013	CcSEcCtD
Fluvastatin—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000347	0.0013	CcSEcCtD
Fluvastatin—Rash—Vincristine—lymphatic system cancer	0.000345	0.00129	CcSEcCtD
Fluvastatin—Dermatitis—Vincristine—lymphatic system cancer	0.000344	0.00129	CcSEcCtD
Fluvastatin—Headache—Vincristine—lymphatic system cancer	0.000343	0.00128	CcSEcCtD
Fluvastatin—Nausea—Carmustine—lymphatic system cancer	0.00034	0.00127	CcSEcCtD
Fluvastatin—Angiopathy—Methotrexate—lymphatic system cancer	0.000339	0.00127	CcSEcCtD
Fluvastatin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000339	0.00127	CcSEcCtD
Fluvastatin—Immune system disorder—Methotrexate—lymphatic system cancer	0.000337	0.00126	CcSEcCtD
Fluvastatin—Rash—Mitoxantrone—lymphatic system cancer	0.000336	0.00126	CcSEcCtD
Fluvastatin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000335	0.00126	CcSEcCtD
Fluvastatin—Chills—Methotrexate—lymphatic system cancer	0.000335	0.00125	CcSEcCtD
Fluvastatin—Headache—Mitoxantrone—lymphatic system cancer	0.000334	0.00125	CcSEcCtD
Fluvastatin—Alopecia—Methotrexate—lymphatic system cancer	0.00033	0.00124	CcSEcCtD
Fluvastatin—Mental disorder—Methotrexate—lymphatic system cancer	0.000327	0.00122	CcSEcCtD
Fluvastatin—Erythema—Methotrexate—lymphatic system cancer	0.000325	0.00122	CcSEcCtD
Fluvastatin—Nausea—Vincristine—lymphatic system cancer	0.000325	0.00122	CcSEcCtD
Fluvastatin—Dysgeusia—Methotrexate—lymphatic system cancer	0.000318	0.00119	CcSEcCtD
Fluvastatin—Nausea—Mitoxantrone—lymphatic system cancer	0.000316	0.00118	CcSEcCtD
Fluvastatin—Back pain—Methotrexate—lymphatic system cancer	0.000314	0.00118	CcSEcCtD
Fluvastatin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000302	0.00113	CcSEcCtD
Fluvastatin—Malaise—Methotrexate—lymphatic system cancer	0.000293	0.0011	CcSEcCtD
Fluvastatin—Vertigo—Methotrexate—lymphatic system cancer	0.000292	0.00109	CcSEcCtD
Fluvastatin—Leukopenia—Methotrexate—lymphatic system cancer	0.000291	0.00109	CcSEcCtD
Fluvastatin—Cough—Methotrexate—lymphatic system cancer	0.000284	0.00106	CcSEcCtD
Fluvastatin—Myalgia—Methotrexate—lymphatic system cancer	0.000277	0.00104	CcSEcCtD
Fluvastatin—Chest pain—Methotrexate—lymphatic system cancer	0.000277	0.00104	CcSEcCtD
Fluvastatin—Arthralgia—Methotrexate—lymphatic system cancer	0.000277	0.00104	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000275	0.00103	CcSEcCtD
Fluvastatin—Discomfort—Methotrexate—lymphatic system cancer	0.000273	0.00102	CcSEcCtD
Fluvastatin—Confusional state—Methotrexate—lymphatic system cancer	0.000268	0.001	CcSEcCtD
Fluvastatin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000265	0.000993	CcSEcCtD
Fluvastatin—Infection—Methotrexate—lymphatic system cancer	0.000264	0.000987	CcSEcCtD
Fluvastatin—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00026	0.000974	CcSEcCtD
Fluvastatin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00026	0.000972	CcSEcCtD
Fluvastatin—Skin disorder—Methotrexate—lymphatic system cancer	0.000258	0.000965	CcSEcCtD
Fluvastatin—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000256	0.00096	CcSEcCtD
Fluvastatin—Anorexia—Methotrexate—lymphatic system cancer	0.000253	0.000947	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000242	0.000905	CcSEcCtD
Fluvastatin—Insomnia—Methotrexate—lymphatic system cancer	0.00024	0.000898	CcSEcCtD
Fluvastatin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000238	0.000892	CcSEcCtD
Fluvastatin—Dyspnoea—Methotrexate—lymphatic system cancer	0.000237	0.000885	CcSEcCtD
Fluvastatin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000234	0.000874	CcSEcCtD
Fluvastatin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000231	0.000863	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000229	0.000857	CcSEcCtD
Fluvastatin—Fatigue—Methotrexate—lymphatic system cancer	0.000229	0.000856	CcSEcCtD
Fluvastatin—Pain—Methotrexate—lymphatic system cancer	0.000227	0.000849	CcSEcCtD
Fluvastatin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000219	0.000818	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000217	0.000812	CcSEcCtD
Fluvastatin—Urticaria—Methotrexate—lymphatic system cancer	0.000211	0.000789	CcSEcCtD
Fluvastatin—Abdominal pain—Methotrexate—lymphatic system cancer	0.00021	0.000785	CcSEcCtD
Fluvastatin—Body temperature increased—Methotrexate—lymphatic system cancer	0.00021	0.000785	CcSEcCtD
Fluvastatin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000195	0.000732	CcSEcCtD
Fluvastatin—Asthenia—Methotrexate—lymphatic system cancer	0.00019	0.000713	CcSEcCtD
Fluvastatin—Pruritus—Methotrexate—lymphatic system cancer	0.000188	0.000703	CcSEcCtD
Fluvastatin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000182	0.00068	CcSEcCtD
Fluvastatin—Dizziness—Methotrexate—lymphatic system cancer	0.000175	0.000657	CcSEcCtD
Fluvastatin—Vomiting—Methotrexate—lymphatic system cancer	0.000169	0.000631	CcSEcCtD
Fluvastatin—Rash—Methotrexate—lymphatic system cancer	0.000167	0.000626	CcSEcCtD
Fluvastatin—Dermatitis—Methotrexate—lymphatic system cancer	0.000167	0.000626	CcSEcCtD
Fluvastatin—Headache—Methotrexate—lymphatic system cancer	0.000166	0.000622	CcSEcCtD
Fluvastatin—Nausea—Methotrexate—lymphatic system cancer	0.000158	0.00059	CcSEcCtD
